Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

39401 - 39410 of 51970 results found

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Date
Tuesday, June 13, 2023 - 4:00 AM
Description
BACKGROUND: Erythropoiesis-stimulating agents (ESAs) are the standard-of-care treatment for anaemia in most patients with lower-risk myelodysplastic syndromes but responses are limited and transient. Luspatercept promotes late-stage erythroid

Virtual Interviews: Outcomes and Lessons Learned

Date
Tuesday, June 13, 2023 - 4:00 AM
Description
CONCLUSIONS: Virtual interviews at our institution did not increase URiM applications to our program from substantial equivalent medical schools. Further research in this area from programs in other states may enhance our understanding of the impact

Meeting Proceedings from ICBS 2022 - Uncovering Solutions for Diseases

Date
Tuesday, June 13, 2023 - 4:00 AM
Description
ICBS 2022 was a refreshing multi-day event where it was justified that the advancement of chemical biology did not halt due to the pandemic, but in contrast, amazing findings were discovered within the restrictions of the SARS-CoV-2 pandemic. All